Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | WANBURY Wanbury Limited Pharma · Small | BAJAJHCARE Bajaj Healthcare Limited Pharma · Small | INNOVANA Innovana Thinklabs Limited Pharma · Small | AHCL Anlon Healthcare Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 60 | 29 | 67 | 55 |
| Verdict | UNDERVALUED | OVERVALUED | UNDERVALUED | FAIR VALUE |
| Style | Growth at Value | OVERVALUED | Growth at Value | FAIR_VALUE |
| Piotroski | 6/9 | 7/9 | 8/9 | 6/9 |
| Valuation | 12/30 | 5/30 | 18/30 | 10/30 |
| Growth | 21/25 | 2/25 | 19/25 | 21/25 |
| Quality | 20/20 | 0/20 | 8/20 | 11/20 |
| Balance Sheet | 0/15 | 9/15 | 12/15 | 10/15 |
| Cash Flow | 4/10 | 7/10 | 4/10 | 0/10 |
| Price | ₹265.75 | ₹292.1 | ₹300.55 | ₹15.14 |
| P/E | 20.50 | 21.10 | 17.00 | 26.20 |
| P/B | 13.92 | 1.87 | 2.37 | 3.26 |
| ROE | 76.50% | 9.40% | 16.00% | 18.40% |
| ROCE | 36.70% | 11.50% | 16.40% | 20.80% |
| Debt / Equity | 3.03 | 0.47 | 0.21 | 0.19 |
| FCF Yield | — | 1.01% | — | — |
| Dividend Y | — | 0.34% | — | — |
| Altman Z | 3.85 | 3.55 | 6.23 | 4.88 |
| Promoter % | 43.01% | 58.29% | 72.65% | 52.68% |
| Mkt Cap (₹Cr) | 882.00 | 992.00 | 647.00 | 747.00 |
| Graham # | ₹73.04 | ₹128.99 | ₹234.15 | ₹7.25 |
| Fair PE | 42.0 | 3.8 | 42.0 | 42.0 |
| MoS % | +51.7% | -1555.4% | +61.2% | +33.2% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startWANBURY102
BAJAJHCARE74
INNOVANA67
AHCL16